Medicine & Life Sciences
Sweden
100%
Costs and Cost Analysis
75%
Chronic Obstructive Pulmonary Disease
63%
Cost-Benefit Analysis
61%
Patient Reported Outcome Measures
41%
Health Care Costs
40%
Quality of Life
32%
Type 1 Diabetes Mellitus
31%
Quality-Adjusted Life Years
30%
Formoterol Fumarate
28%
Budesonide
26%
Obesity
21%
Type 2 Diabetes Mellitus
20%
Cost of Illness
20%
Crohn Disease
19%
Registries
18%
Formoterol Fumarate Drug Combination Budesonide
18%
ferric carboxymaltose
17%
Delivery of Health Care
16%
Nebulizers and Vaporizers
16%
Ulcerative Colitis
16%
pomalidomide
16%
Drug Costs
16%
Diabetes Complications
15%
Asthma
15%
Population
15%
Disease Progression
14%
Economic Models
14%
Fluticasone
13%
Cross-Sectional Studies
13%
Budgets
13%
Economics
13%
Reproducibility of Results
12%
Information Storage and Retrieval
12%
Mortality
12%
Denmark
12%
Patient-Centered Care
12%
Inflammatory Bowel Diseases
10%
Precision Medicine
10%
Health
10%
Natural History
10%
Overweight
10%
Disease Management
10%
Multiple Myeloma
10%
Computer Simulation
9%
Therapeutics
9%
Multiple Sclerosis
8%
Parkinson Disease
8%
Iron
8%
Body Mass Index
8%
Social Sciences
chronic illness
31%
Sweden
28%
costs
26%
quality of life
21%
Health Economics
17%
model comparison
14%
decision model
14%
chronic condition
12%
simulation model
12%
life years
12%
economic model
11%
computer simulation
11%
economic impact
10%
relapse
10%
mortality
10%
cross-sectional study
10%
hospital care
9%
scenario
8%
cardiovascular disease
8%
medicine
8%
patient care
7%
hospitalization
7%
public health care delivery system
7%
health
6%
efficiency analysis
6%
Clinical Trials
5%
Euro
5%
history
5%
